Neutropenia, Severe Congenital, 2, Autosomal Dominant disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

SCN2 MCID: NTR051 MIFTS: 23	Neutropenia, Severe Congenital, 2, Autosomal Dominant (SCN2) Categories: Blood diseases, Bone diseases, Genetic diseases, Immune diseases, Rare diseases
Genes Variations Tissues Publications Symptoms & Phenotypes Drugs Expand all tables

Sources

Aliases & Classifications for Neutropenia, Severe Congenital, 2, Autosomal Dominant

MalaCards integrated aliases for Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Name: Neutropenia, Severe Congenital, 2, Autosomal Dominant ⁵⁸

Neutropenia, Severe Congenital 2, Autosomal Dominant ⁵⁸ ⁷⁶ ¹³

Severe Congenital Neutropenia 2, Autosomal Dominant ³⁰ ⁶

Scn2 ⁵⁸ ⁷⁶

Neutropenia, Congenital, Severe, Type 2, Autosomal Dominant ⁴¹

Neutropenia, Severe Congenital, Autosomal Dominant 2 ⁷⁴

Characteristics:

OMIM:

⁵⁸

Inheritance:
autosomal dominant

HPO:

³³

neutropenia, severe congenital, 2, autosomal dominant:
Inheritance autosomal dominant inheritance

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases
Anatomical: Blood diseases Immune diseases Bone diseases

See all MalaCards categories (disease lists)

External Ids:

OMIM ⁵⁸ 613107

MeSH ⁴⁵ D009503

MedGen ⁴³ C2751288

SNOMED-CT via HPO ⁷⁰ 165517008 19636003 263681008

UMLS ⁷⁴ C2751288

Sources

Summaries for Neutropenia, Severe Congenital, 2, Autosomal Dominant

UniProtKB/Swiss-Prot : ⁷⁶ Neutropenia, severe congenital 2, autosomal dominant: A disorder of hematopoiesis characterized by maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0.5 x 10(9)/l and early onset of severe bacterial infections.

MalaCards based summary : Neutropenia, Severe Congenital, 2, Autosomal Dominant, is also known as neutropenia, severe congenital 2, autosomal dominant. An important gene associated with Neutropenia, Severe Congenital, 2, Autosomal Dominant is GFI1 (Growth Factor Independent 1 Transcriptional Repressor). The drug Psychotropic Drugs has been mentioned in the context of this disorder. Affiliated tissues include neutrophil, monocytes and bone, and related phenotypes are neutropenia and b lymphocytopenia

Description from OMIM: 613107

Sources

Related Diseases for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Diseases in the Neutropenia family:

Neutropenia, Chronic Familial	Neutropenia, Severe Congenital, 1, Autosomal Dominant
Neutropenia, Severe Congenital, 3, Autosomal Recessive	Neutropenia, Severe Congenital, 4, Autosomal Recessive
Neutropenia, Severe Congenital, 2, Autosomal Dominant	Neutropenia, Severe Congenital, 5, Autosomal Recessive
Neutropenia, Severe Congenital, 6, Autosomal Recessive	Neutropenia, Severe Congenital, 7, Autosomal Recessive
Severe Congenital Neutropenia	Elane-Related Neutropenia
Severe Congenital Neutropenia Autosomal Dominant

Sources

Symptoms & Phenotypes for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Human phenotypes related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

³³

#	Description	HPO Source Accession
1	neutropenia ³³	HP:0001875
2	b lymphocytopenia ³³	HP:0010976
3	monocytosis ³³	HP:0012311

Symptoms via clinical synopsis from OMIM:

⁵⁸

Immunology:
elevated monocytes
low neutrophil number
immature neutrophils
immature monocytes
reduced absolute cell number of cd4 t lymphocytes
more

Clinical features from OMIM:

613107

Sources

Drugs & Therapeutics for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Drugs for Neutropenia, Severe Congenital, 2, Autosomal Dominant (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

#		Name	Status	Phase	Clinical Trials	Cas Number	PubChem Id
1		Psychotropic Drugs		Phase 4

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Clinical Utility of Pharmacogenomics of Psychotropic Medications	Not yet recruiting	NCT03907124	Phase 4	Genetically-guided treatment with FDA-approved psychotropic drugs;Treatment as usual (TAU)
2	Online Study of Individuals With Genetic Changes and Features of Autism: Simons Variation in Individuals Project (Simons VIP)	Recruiting	NCT01238250

Search NIH Clinical Center for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Sources

Genetic Tests for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Genetic tests related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

#	Genetic test	Affiliating Genes
1	Severe Congenital Neutropenia 2, Autosomal Dominant ³⁰	GFI1

Sources

Anatomical Context for Neutropenia, Severe Congenital, 2, Autosomal Dominant

MalaCards organs/tissues related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

⁴²

Neutrophil, Monocytes, Bone

Sources

Publications for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Articles related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

#	Title	Authors	Year
1	Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. ( 12778173 )	Person RE...Horwitz M	2003

Sources

Genes for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Genes related to Neutropenia, Severe Congenital, 2, Autosomal Dominant (1 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	GFI1	Growth Factor Independent 1 Transcriptional Repressor	Protein Coding	1377.66	Molecular basis known ⁵⁸ Pathogenic ⁶ Causative variation ⁷⁶ Genetic Tests ³⁰ Unconfirmed association ⁵⁸ GeneCards inferred via : Disorders Variants (show sections)	12778173

Sources

Variations for Neutropenia, Severe Congenital, 2, Autosomal Dominant

UniProtKB/Swiss-Prot genetic disease variations for Neutropenia, Severe Congenital, 2, Autosomal Dominant:

⁷⁶

#	Symbol	AA change	Variation ID	SNP ID
1	GFI1	p.Asn382Ser	VAR_016212	rs28936381

ClinVar genetic disease variations for Neutropenia, Severe Congenital, 2, Autosomal Dominant:

⁶ (show all 46)

#	Gene	Variation	Type	Significance	SNP ID	Assembly	Location
1	GFI1	NM_005263.4(GFI1): c.1145A> G (p.Asn382Ser)	single nucleotide variant	Pathogenic	rs28936381	GRCh37	Chromosome 1, 92941710: 92941710
2	GFI1	NM_005263.4(GFI1): c.1145A> G (p.Asn382Ser)	single nucleotide variant	Pathogenic	rs28936381	GRCh38	Chromosome 1, 92476153: 92476153
3	GFI1	NM_005263.3(GFI1): c.1047C> T (p.Phe349=)	single nucleotide variant	Benign/Likely benign	rs80337126	GRCh38	Chromosome 1, 92478631: 92478631
4	GFI1	NM_005263.3(GFI1): c.1047C> T (p.Phe349=)	single nucleotide variant	Benign/Likely benign	rs80337126	GRCh37	Chromosome 1, 92944188: 92944188
5	GFI1	NM_005263.3(GFI1): c.718G> C (p.Glu240Gln)	single nucleotide variant	Benign/Likely benign	rs6666973	GRCh38	Chromosome 1, 92480669: 92480669
6	GFI1	NM_005263.3(GFI1): c.718G> C (p.Glu240Gln)	single nucleotide variant	Benign/Likely benign	rs6666973	GRCh37	Chromosome 1, 92946226: 92946226
7	GFI1	NM_005263.3(GFI1): c.648A> G (p.Ala216=)	single nucleotide variant	Benign	rs114464352	GRCh38	Chromosome 1, 92480739: 92480739
8	GFI1	NM_005263.3(GFI1): c.648A> G (p.Ala216=)	single nucleotide variant	Benign	rs114464352	GRCh37	Chromosome 1, 92946296: 92946296
9	GFI1	NM_005263.3(GFI1): c.319C> G (p.Pro107Ala)	single nucleotide variant	Likely benign	rs149914857	GRCh38	Chromosome 1, 92481068: 92481068
10	GFI1	NM_005263.3(GFI1): c.319C> G (p.Pro107Ala)	single nucleotide variant	Likely benign	rs149914857	GRCh37	Chromosome 1, 92946625: 92946625
11	GFI1	NM_005263.3(GFI1): c.168C> T (p.Ser56=)	single nucleotide variant	Benign/Likely benign	rs143913803	GRCh37	Chromosome 1, 92948551: 92948551
12	GFI1	NM_005263.3(GFI1): c.168C> T (p.Ser56=)	single nucleotide variant	Benign/Likely benign	rs143913803	GRCh38	Chromosome 1, 92482994: 92482994
13	GFI1	NM_005263.3(GFI1): c.107G> A (p.Ser36Asn)	single nucleotide variant	Benign	rs34631763	GRCh38	Chromosome 1, 92483381: 92483381
14	GFI1	NM_005263.3(GFI1): c.107G> A (p.Ser36Asn)	single nucleotide variant	Benign	rs34631763	GRCh37	Chromosome 1, 92948938: 92948938
15	GFI1	NM_005263.3(GFI1): c.925-14_925-5dupCTCTCTCTCT	duplication	Conflicting interpretations of pathogenicity	rs35896485	GRCh38	Chromosome 1, 92478758: 92478767
16	GFI1	NM_005263.3(GFI1): c.925-14_925-5dupCTCTCTCTCT	duplication	Conflicting interpretations of pathogenicity	rs35896485	GRCh37	Chromosome 1, 92944315: 92944324
17	GFI1	NM_005263.3(GFI1): c.1032C> T (p.Tyr344=)	single nucleotide variant	Likely benign	rs139144506	GRCh38	Chromosome 1, 92478646: 92478646
18	GFI1	NM_005263.3(GFI1): c.1032C> T (p.Tyr344=)	single nucleotide variant	Likely benign	rs139144506	GRCh37	Chromosome 1, 92944203: 92944203
19	GFI1	NM_005263.3(GFI1): c.925-8_925-5delCTCT	deletion	Conflicting interpretations of pathogenicity	rs35896485	GRCh38	Chromosome 1, 92478758: 92478761
20	GFI1	NM_005263.3(GFI1): c.925-8_925-5delCTCT	deletion	Conflicting interpretations of pathogenicity	rs35896485	GRCh37	Chromosome 1, 92944315: 92944318
21	GFI1	NM_005263.3(GFI1): c.925-14_925-5delCTCTCTCTCT	deletion	Conflicting interpretations of pathogenicity	rs35896485	GRCh38	Chromosome 1, 92478758: 92478767
22	GFI1	NM_005263.3(GFI1): c.925-14_925-5delCTCTCTCTCT	deletion	Conflicting interpretations of pathogenicity	rs35896485	GRCh37	Chromosome 1, 92944315: 92944324
23	GFI1	NM_005263.3(GFI1): c.925-18_925-5dupCTCTCTCTCTCTCT	duplication	Conflicting interpretations of pathogenicity	rs35896485	GRCh37	Chromosome 1, 92944315: 92944328
24	GFI1	NM_005263.3(GFI1): c.925-18_925-5dupCTCTCTCTCTCTCT	duplication	Conflicting interpretations of pathogenicity	rs35896485	GRCh38	Chromosome 1, 92478758: 92478771
25	GFI1	NM_005263.3(GFI1): c.792C> T (p.Phe264=)	single nucleotide variant	Benign/Likely benign	rs114487177	GRCh37	Chromosome 1, 92946037: 92946037
26	GFI1	NM_005263.3(GFI1): c.792C> T (p.Phe264=)	single nucleotide variant	Benign/Likely benign	rs114487177	GRCh38	Chromosome 1, 92480480: 92480480
27	GFI1	NM_005263.3(GFI1): c.925-12_925-5dupCTCTCTCT	duplication	Conflicting interpretations of pathogenicity	rs35896485	GRCh38	Chromosome 1, 92478758: 92478765
28	GFI1	NM_005263.3(GFI1): c.925-12_925-5dupCTCTCTCT	duplication	Conflicting interpretations of pathogenicity	rs35896485	GRCh37	Chromosome 1, 92944315: 92944322
29	GFI1	NM_005263.4(GFI1): c.1198C> T (p.Leu400Phe)	single nucleotide variant	Benign	rs143708376	GRCh37	Chromosome 1, 92941657: 92941657
30	GFI1	NM_005263.4(GFI1): c.1198C> T (p.Leu400Phe)	single nucleotide variant	Benign	rs143708376	GRCh38	Chromosome 1, 92476100: 92476100
31	GFI1	NM_005263.4(GFI1): c.925-12_925-5delCTCTCTCT	deletion	Benign	rs35896485	GRCh38	Chromosome 1, 92478758: 92478765
32	GFI1	NM_005263.4(GFI1): c.925-12_925-5delCTCTCTCT	deletion	Benign	rs35896485	GRCh37	Chromosome 1, 92944315: 92944322
33	GFI1	NM_005263.4(GFI1): c.483T> C (p.Pro161=)	single nucleotide variant	Benign	rs374062963	GRCh38	Chromosome 1, 92480904: 92480904
34	GFI1	NM_005263.4(GFI1): c.483T> C (p.Pro161=)	single nucleotide variant	Benign	rs374062963	GRCh37	Chromosome 1, 92946461: 92946461
35	GFI1	NM_005263.4(GFI1): c.804C> T (p.His268=)	single nucleotide variant	Likely benign	rs376949976	GRCh38	Chromosome 1, 92480468: 92480468
36	GFI1	NM_005263.4(GFI1): c.804C> T (p.His268=)	single nucleotide variant	Likely benign	rs376949976	GRCh37	Chromosome 1, 92946025: 92946025
37	GFI1	NM_005263.4(GFI1): c.-14A> C	single nucleotide variant	Benign	rs200972824	GRCh38	Chromosome 1, 92483501: 92483501
38	GFI1	NM_005263.4(GFI1): c.772A> G (p.Ile258Val)	single nucleotide variant	Uncertain significance	rs755193129	GRCh38	Chromosome 1, 92480615: 92480615
39	GFI1	NM_005263.4(GFI1): c.772A> G (p.Ile258Val)	single nucleotide variant	Uncertain significance	rs755193129	GRCh37	Chromosome 1, 92946172: 92946172
40	GFI1	NM_005263.4(GFI1): c.-14A> C	single nucleotide variant	Benign	rs200972824	GRCh37	Chromosome 1, 92949058: 92949058
41	GFI1	NM_005263.4(GFI1): c.925-20_925-5dup	duplication	Benign	rs35896485	GRCh37	Chromosome 1, 92944315: 92944330
42	GFI1	NM_005263.4(GFI1): c.925-20_925-5dup	duplication	Benign	rs35896485	GRCh38	Chromosome 1, 92478758: 92478773
43	GFI1	NM_005263.4(GFI1): c.477G> A (p.Pro159=)	single nucleotide variant	Uncertain significance		GRCh37	Chromosome 1, 92946467: 92946467
44	GFI1	NM_005263.4(GFI1): c.477G> A (p.Pro159=)	single nucleotide variant	Uncertain significance		GRCh38	Chromosome 1, 92480910: 92480910
45	GFI1	NM_005263.4(GFI1): c.938A> G (p.Asp313Gly)	single nucleotide variant	Uncertain significance		GRCh37	Chromosome 1, 92944297: 92944297
46	GFI1	NM_005263.4(GFI1): c.938A> G (p.Asp313Gly)	single nucleotide variant	Uncertain significance		GRCh38	Chromosome 1, 92478740: 92478740

Sources

Expression for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Search GEO for disease gene expression data for Neutropenia, Severe Congenital, 2, Autosomal Dominant.

Sources

Pathways for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Sources

GO Terms for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Sources

Sources for Neutropenia, Severe Congenital, 2, Autosomal Dominant

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia

Neutropenia, Severe Congenital, 2, Autosomal Dominant (SCN2)

Aliases & Classifications for Neutropenia, Severe Congenital, 2, Autosomal Dominant

MalaCards integrated aliases for Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Characteristics:

OMIM:

HPO:

Classifications:

External Ids:

Summaries for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Related Diseases for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Diseases in the Neutropenia family:

Symptoms & Phenotypes for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Human phenotypes related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Symptoms via clinical synopsis from OMIM:

Clinical features from OMIM:

Drugs & Therapeutics for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Drugs for Neutropenia, Severe Congenital, 2, Autosomal Dominant (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Genetic Tests for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Genetic tests related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Anatomical Context for Neutropenia, Severe Congenital, 2, Autosomal Dominant

MalaCards organs/tissues related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Publications for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Articles related to Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Genes for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Genes related to Neutropenia, Severe Congenital, 2, Autosomal Dominant (1 elite genes):

Variations for Neutropenia, Severe Congenital, 2, Autosomal Dominant

UniProtKB/Swiss-Prot genetic disease variations for Neutropenia, Severe Congenital, 2, Autosomal Dominant:

ClinVar genetic disease variations for Neutropenia, Severe Congenital, 2, Autosomal Dominant:

Expression for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Pathways for Neutropenia, Severe Congenital, 2, Autosomal Dominant

GO Terms for Neutropenia, Severe Congenital, 2, Autosomal Dominant

Sources for Neutropenia, Severe Congenital, 2, Autosomal Dominant